ViiV's HIV Treatment Dolutegravir Will Get FDA Priority Review

Published February 17, 2013

ViiV's HIV Treatment Dolutegravir Will Get FDA Priority Review

Filed under: drug treatment programs in nyc

The FDA gave dolutegravir priority review status, which is granted to drugs that have the potential to offer significant improvement over existing therapies or where no adequate treatment exists, the company said. Dolutegravir may challenge the world's …
Read more on Bloomberg

Propecia Lawsuits: Next Status Conference in New Jersey Propecia Litigation …

Filed under: drug treatment programs in nyc

Propecia was approved by the U.S. Food & Drug Administration (FDA) in 1997 as a treatment for male pattern hair loss. Propecia prevents the conversion of testosterone to dihydrotestoterone (DHT) in the body, which has been implicated in the balding …
Read more on DigitalJournal.com (press release)

Jaw Pain – Find the Remedy

Filed under: drug treatment programs in nyc

Learn what it takes to eat healthy, decipher labels, lose weight naturally and plan nutritional meals. Fitness … She graduated with her D.D.S (Doctor of Dental Surgery) in 2004 from New York University College of Dentistry, New York. She lives in …
Read more on Our Colorado News